BACIO-study
The aims of the The Bergen Atherosclerosis and Cardiac bIOmarker (BACIO) Study is to assess the diagnostic and prognostic accuracy of established and novel cardiovascular biomarkers in chest pain patients ruled out for AMI, using cardiac imaging findings and clinical events as the outcome measures.
The study further aims to identify determinants of chronic elevation of cardiac troponins and other novel biomarkers in chest pain patients ruled out for AMI and finally to describe relation between novel biomarkers related to pathophysiological mechanisms for atherosclerosis and traditional inflammatory and myocardial necrosis markers
The data collection was finalized in November 2023. Two PhD projects are currently affiliated to the project and another PhD application is in progress.
For more information, see The Bergen Atherosclerosis and Cardiac bIOmarker (BACIO) Study